DRF-8417

• UNSPSC Description:

  DRF-8417, an oxazolidinone antibiotic, is active against Gram-positive and fastidious Gram-negative bacteria. DRF 8417 exhibits potent activity against Gram-positive pathogens with MIC50 and MIC90 values ranging from 0.06 to 1 mg/L[1][2].

• Target Antigen:

  Antibiotic; Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/drf-8417.html

• Smiles:

  O=C1N(C2=CC=C(N3C(OCC3)=O)C=C2)C[C@@H](O1)CNC(OC)=S

• Molecular Weight:

  351.38

• References & Citations:

  [1]K Sreenivas, et al. In vitro and in vivo antibacterial evaluation of DRF 8417, a new oxazolidinone. J Antimicrob Chemother. 2007 Jul;60(1):159-61.|[2]Mahesh V. Patel, et al. Indian Discovery Effort in the Quest of Novel Antibiotics. Drug Discovery and Drug Development. 11 February 2021.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  439903-56-7